Indacaterol: a new once daily long-acting beta(2) adrenoceptor agonist

INTRODUCTION: Indacaterol is a novel once daily long-acting beta agonist (LABA) developed for the treatment of chronic obstructive pulmonary disease (COPD) and asthma. AIMS: This review summarizes preclinical and clinical data of indacaterol, including all data generated during the phase II trial pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Beeh, Kai M, Beier, Jutta
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2899782/
https://www.ncbi.nlm.nih.gov/pubmed/20694063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2899782/
https://www.ncbi.nlm.nih.gov/pubmed/20694063

Ejemplares similares